FDA Warning – 247meds. com

Buying Prescription Scam Alert 1Drugs Online May Be Dangerous Says Drug Enforcement Administration

DEA Logo - Buying Percription Drugs

National Association of Boards of Pharmacy (NABP)


“The Canadian Pharmacy, Canadian/European Pharmacy”, “Canadian Healthcare” and “US Drugstore” are brands of one of the most disgusting illegal online pharmacy group well organized CRIMINAL OPERATION of all times. “GREED” is the driving force behind this operation. Don’t let them fool you. They will never send you any genuine drugs. If they ever send anything at all, it may consist of literally anything from sugar to wall plaster, and they certainly don’t care that you will endanger your health by taking those dangerous counterfeit drugs.

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

There are many options out there when it comes to buying medication online. We have looked at websites after websites. Some sites feature offshore pharmacies that do not require a prior prescription. Others feature licensed pharmacies that do require a prescription from your doctor.
Before making a purchase that can effect your health, we strongly recommend that you consult your physician & DO NOT self-medicate. Ordering medication online can be a safe, money-saving experience. When done through licensed online pharmacies that require a prescription, you can be assured that the medication you get is exactly what you need to treat your ailments.

From: FDA Center for Drug Evaluation and Research

Date: November 16, 2009                                                          

TO: Ric Deleon
21 Villamor Street
Manila, Manila 2700

TO: Ric Deleon
FROM: Food and Drug Administration Internet Pharmacy Task Force
RE: Internet Marketing of Unapproved and Misbranded Drugs
DATE: November 16, 2009


The United States Food and Drug Administration (FDA) has reviewed your websites at

and has determined that you are offering products for sale in violation of the Federal Food, Drug, and Cosmetic Act (the Act). These products include, but are not limited to, “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,” “Herbal Ambien,” “Herbal Viagra,” “Viagra (Brand),” “Xanax (Brand),” and “Valium (Brand).” We request that you immediately cease marketing violative products.

These products are drugs under section 201 (g) of the Act, 21 U.S.C. § 321 (g), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. Your marketing and distribution of these drugs violate various provisions of the Act, as described below:

Unapproved New Drugs

Your firm offers many unapproved new drugs including, but not limited to Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,· “Herbal Ambien,· and “Herbal Viagra.” FDA
is taking this action against your firm because of the inherent risk in buying unapproved prescription drugs. Unapproved drugs from unregulated sources do not have the same assurance of safety and effectiveness as drugs subject to FDA oversight and have been found to be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether. For drugs that are regulated by FDA, FDA protections include rigorous scientific standards for prescription drug approval and label review for accuracy and completeness, manufacturing procedures and testing performed under closely controlled conditions at FDA-registered and inspected facilities. In addition, pharmacies and wholesalers who sell or distribute prescription drugs in the U.S. are licensed by the states. Unapproved new drugs delivered to the American public from unregulated sources may not be safe and effective.

Rimonabant (also marketed under the name Acomplia) was specifically rejected for FDA approval because it did not meet the statutory requirements for safety and effectiveness. In June 2007, the FDA Endocrinologic and Metabolic Drugs Advisory Committee unanimously voted not to recommend approval of the drug because of increased risk of neurological and psychiatric side effects including seizures, depression, anxiety, insomnia, aggressiveness, and suicidal thoughts
among patients. Accordingly, the “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant,” dispensed through your websites are “new drugs,” as defined by section 201 (p) of the Act, 21 U.S.C. § 321(p), because it is not generally recognized as safe and effective for its labeled uses.

You also offer “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” on your websites. Xanax, Ambien, and Viagra are approved drugs well-known for their intended use(s) to treat disease.
Therefore, including these drug names causes “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” to be subject to regulation as drugs under Section 201 (g) of the Act because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.
Moreover, these products are new drugs, as defined by section 201 (p) of the Act, 21 U.S.C. § 321 (p).

Under sections 301 (d) and 505(a) of the Act, 21 U.S.C. §§ 331 (d) and 355(a), a new drug may not be introduced or delivered for introduction into interstate commerce unless an FDA-approved application is in effect for it. Your sale of several products, including but not limited to “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra,” without approved applications violates these provisions of the Act.

Misbranded Drugs

Your websites offer several products, including but not limited to “Viagra (Brand),” “Xanax (Brand),” and “Valium (Brand),” for sale without requiring that the products be dispensed under a prescription from a duly licensed practitioner. Some of the products available on your website are also controlled substances; the sale of these products is particularly concerning because of the potential for abuse and dependency. Therefore, the drugs are misbranded under section
503(b)(1) of the Act, 21 U.S.C. § 353(b)(1), and are marketed in violation of sections 301 (a), 301 (b), and 301 (k) of such Act, 21 U.S.C. §§ 331 (a), 331 (b), and 331 (k).

Further, your websites offer products for sale and state that they are FDA-approved. As noted above, your products are not FDA-approved and are offered for sale in violation of the Act.
Therefore, these products are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs is false and misleading.

In addition, you offer “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” for sale. These drugs are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs are false and misleading. The labeling are false and misleading because they erroneously suggest that the products contain Xanax, Ambien, and Viagra, which are the proprietary names for FDA-approved products containing the active pharmaceutical ingredients alprazolam,
zolpidem, and sildenafil citrate. Regardless of whether your products contain Xanax, Ambien, or Viagra, the products you are offering for sale are not manufactured by the sponsors of the approved applications for Xanax, Ambien, or Viagra, and it is false and misleading to suggest that
your products are manufactured by that sponsor.

The introduction or delivery for introduction into interstate commerce of these misbranded products violates section 301 (a) of the Act, 21 U.S.C. § 331 (a).

This letter is not intended to identify all of the ways in which your activities might be in violation of United States law. It is your responsibility to ensure that all products marketed by your firm are in compliance with the Act and its implementing regulations. You should take prompt action to correct the violations noted above. Failure to correct these violations promptly may result in regulatory action, including but not limited to, seizure and/or injunction without further notice.

Please notify this office in writing within 15 working days of receipt of this letter of any steps you have taken or will take to correct the noted violations and to prevent their recurrence. If the corrective action(s) cannot be completed within 15 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response should be sent to FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov. Please direct any inquiries concerning this letter to FDA’s Internet Pharmacy Task Force at FDAlnternetPharmacyTaskForceCDER@fda.hhs.gov or (301) 796-3110.


Deborah M. Autor, Esq.
Office of Compliance

Address lookup

lookup failed 247meds. com
Could not find an IP address for this domain name.

Domain Whois record

Queried with “247meds. com”…

Query error: NoWhoisServerForDomain

Network Whois record

Don’t have an IP address for which to get a record

DNS records

DNS query for 247meds. com returned an error from the server: NameError

No records to display
— end —

IP address:
Host name: 247meds.com
247meds.com is from United States(US) in region North America

TraceRoute to [247meds.com]
Hop (ms) (ms) (ms) IP Address Host name
1 30 61 57 –
2 52 35 11 xe-5-3-0.edge3.dallas1.level3.net
3 7 18 30 ae-93-90.ebr3.dallas1.level3.net
4 55 26 36 ae-7-7.ebr3.atlanta2.level3.net
5 32 31 26 ae-73-73.csw2.atlanta2.level3.net
6 33 28 28 ae-22-52.car2.atlanta1.level3.net
7 29 26 25 nationalnet.atlanta1.level3.net
8 30 35 44 gig2-10.tr1.atl4.national-net.com
9 62 57 42 pillcart.com
Trace complete

Retrieving DNS records for 247meds.com…
DNS servers

Answer records
247meds.com NS ns1.nationalnet.com 900s
247meds.com A 900s
247meds.com SOA
server: ns1.nationalnet.com
email: dnsadmin@nationalnet.com
serial: 2008042501
refresh: 28800
retry: 7200
expire: 604800
minimum ttl: 86400
247meds.com NS ns2.nationalnet.com 900s

Authority records

Additional records
ns1.nationalnet.com A 900s
ns2.nationalnet.com A 900s

Whois query for 247meds.com
Results returned from whois.internic.net:

Domain Name: 247MEDS.COM
Registrar: GODADDY.COM, INC.
Whois Server: whois.godaddy.com
Referral URL: http://registrar.godaddy.com
Status: clientDeleteProhibited
Status: clientRenewProhibited
Status: clientTransferProhibited
Status: clientUpdateProhibited
Updated Date: 20-dec-2010
Creation Date: 11-mar-2003
Expiration Date: 11-mar-2012

Last update of whois database: Thu, 13 Jan 2011 11:43:14 UTC
Ric Deleon

Registered through: GoDaddy.com, Inc. (http://www.godaddy.com)
Domain Name: 247MEDS.COM

Domain servers in listed order:

For complete domain details go to:
Network IP address lookup:

Whois query for
Results returned from whois.arin.net:

The following results may also be obtained via:

NationalNet, Managed Services NATNET-MANAGED-VL255-BLK14 (NET-66-115-142-0-1) –
NationalNet, Inc. NATIONALNET-1 (NET-66-115-128-0-1) –

ARIN WHOIS data and services are subject to the Terms of Use
available at: https://www.arin.net/whois_tou.html

Results returned from whois.arin.net:

The following results may also be obtained via:

NetRange: –
OriginAS: AS22384
NetHandle: NET-66-115-142-0-1
Parent: NET-66-115-128-0-1
NetType: Reassigned
RegDate: 2010-04-21
Updated: 2010-04-21
Ref: http://whois.arin.net/rest/net/NET-66-115-142-0-1

CustName: NationalNet, Managed Services
Address: 1130 Powers Ferry Place SE
City: Marietta
StateProv: GA
PostalCode: 30067
Country: US
RegDate: 2010-04-21
Updated: 2010-04-21
Ref: http://whois.arin.net/rest/customer/C02472880

OrgNOCHandle: NNO76-ARIN
OrgNOCName: NationalNet Network Operations
OrgNOCPhone: +1-678-247-7000
OrgNOCEmail: noc@nationalnet.com
OrgNOCRef: http://whois.arin.net/rest/poc/NNO76-ARIN

OrgTechHandle: IA88-ARIN
OrgTechName: IP Administrator
OrgTechPhone: +1-678-247-7000
OrgTechEmail: ipadmin@nationalnet.com
OrgTechRef: http://whois.arin.net/rest/poc/IA88-ARIN

OrgAbuseHandle: NAC69-ARIN
OrgAbuseName: NationalNet Abuse Contact
OrgAbusePhone: +1-678-247-7000
OrgAbuseEmail: abuse@nationalnet.com
OrgAbuseRef: http://whois.arin.net/rest/poc/NAC69-ARIN

RTechHandle: IA88-ARIN
RTechName: IP Administrator
RTechPhone: +1-678-247-7000
RTechEmail: ipadmin@nationalnet.com
RTechRef: http://whois.arin.net/rest/poc/IA88-ARIN

ARIN WHOIS data and services are subject to the Terms of Use
available at: https://www.arin.net/whois_tou.html

Other Known Domains Associated With This Group

  1. stimulhosting.com
  2. medpill.stimulhosting.com
  3. 247-meds.com
  4. relay.247-meds.com
  5. abouthealthy.com
  6. afmstore.com
  7. alfapills.com
  8. all-medication.com
  9. artelimbo.com
  10. best-pills-online.com
  11. bestpharmacyonline.net
  12. buy-pharmacy.info
  13. calidrugs.net
  14. ciais.net
  15. cvs-pharmacy.biz
  16. drug-store-online.net
  17. drugs24.net
  18. drugsline.net
  19. drugswebonline.com
  20. echeap-drugs.com
  21. extracheapdrugs.com
  22. firm-pharmacy.com
  23. freewebdav.com
  24. ftonk.com
  25. genericdrugsareus.com
  26. gldpharmacy.com
  27. govardwool.com
  28. idrugmall.com
  29. janomestaging.com
  30. jofk.com
  31. love-pharmacy.org
  32. many-shop.com
  33. medications.stimulhosting.com
  34. medprivacy.net
  35. my-web-pills.com
  36. ns0.stimulhosting.com
  37. ns1.alfapills.com
  38. ns1.buy-pharmacy.info
  39. ns1.cvs-pharmacy.biz
  40. ns1.love-pharmacy.org
  41. ns1.medm.net
  42. ns1.pharmacyvia.net
  43. ns1.pittlearningsolutions.net
  44. ns1.stimulhosting.com
  45. ns1.worldsbestpharmacy.net
  46. ns2.alfapills.com
  47. ns2.buy-pharmacy.info
  48. ns2.cvs-pharmacy.biz
  49. ns2.love-pharmacy.org
  50. ns2.medm.net
  51. ns2.pharmacyvia.net
  52. ns2.pittlearningsolutions.net
  53. ns1.stimulhosting.com
  54. ns1.worldsbestpharmacy.net
  55. ns2.alfapills.com
  56. ns2.buy-pharmacy.info
  57. ns2.cvs-pharmacy.biz
  58. ns2.love-pharmacy.org
  59. ns2.medm.net
  60. ns2.pharmacyvia.net
  61. ns2.pittlearningsolutions.net
  62. ns2.worldsbestpharmacy.net
  63. onlinepharmacyfda.com
  64. order-cheap-meds.com
  65. orgasm-drugstore.com
  66. ovvl.com
  67. parcialis.com
  68. pharma37.com
  69. pharmacy-54.com
  70. pharmacytop.com
  71. pharmacyvia.net
  72. pharmamexpills.com
  73. pharmamexstore.com
  74. pharmamixx.com
  75. pharmocean.com
  76. pill-s.net
  77. pills-buy-now.com
  78. pillsmarket.net
  79. pillsstore.net
  80. relay.alfapills.com
  81. relay.buy-pharmacy.info
  82. relay.cvs-pharmacy.biz
  83. relay.love-pharmacy.org
  84. relay.medm.net
  85. relay.my-web-pills.com
  86. relay.nypdfoyle.com
  87. relay.pharmacyvia.net
  88. relay.pill-s.net
  89. relay.worldsbestpharmacy.net
  90. retreadthreads.com
  91. rksu.com
  92. rpvo.com
  93. rx-review.com
  94. s-pills.com
  95. shinkatech.com
  96. sleline.com
  97. stimulhosting.com
  98. takeyourdrug.com
  99. thedrugmarket.com
  100. thepharmacy24.com
  101. top-medications.com
  102. ukusdrugs.com
  103. unkp.com
  104. usadrugsite.com
  105. viagr.net
  106. vkak.com
  107. wdxp.com
  108. wkum.com
  109. worldsbestpharmacy.net
  110. wvvd.com
  111. your-tablets.com

One thought on “FDA Warning – 247meds. com

Leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.